Biopharma Takes Wait & See Approach
Shanghai Free Trade Zone Aims to Inspire Foreign Investment
By Shannon Ellis
Friday, October 11, 2013
SHANGHAI – A much-awaited free trade zone in Shanghai may eventually create some opportunities for biotechs, but nothing will happen overnight. As China’s health care reform juggernaut continues, foreign investment in hospitals and insurance is part of the much-touted Shanghai Free Trade Zone (FTZ), a pilot zone launched on Sept. 30.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.